OGN:NYSE
Organon & Co
$13.79
arrow_upward
+0.36%(+0.050) 1D
$13.79
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:09 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
$13.72
High
$13.79
Low
$13.72
Mkt. cap
3.62B
Avg. vol.
2.71M
Volume
2.21M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.67
52-wk high
$13.79
52-wk low
$5.69
EPS
$0.78
Beta
1.55
Shares outstanding
262.61M
No. of employees
10K
Open
$13.72
High
$13.79
Low
$13.72
Mkt. cap
3.62B
Avg. vol.
2.71M
Volume
2.21M
Dividend
0.58%
Quarterly dividend
$0.02
Ex-dividend date
Aug 14, 2026
P/E ratio
17.67
52-wk high
$13.79
52-wk low
$5.69
EPS
$0.78
Beta
1.55
Shares outstanding
262.61M
No. of employees
10K
News stories
From web sources and news partners
Investing.com
·
4 hours ago
Organon & Co stock hits 52-week high at 13.79 USD
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10K
Founded1923
HeadquartersJersey City, New Jersey, United States
SectorPharmaceutical industry
Websiteorganon.com